Globeflex Capital L P Cytom X Therapeutics, Inc. Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $106,235 - $200,667	-69,435 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $200,158 - $297,921	-46,333 Reduced 40.02%	69,435 $353,000
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $765 - $1,199	121 Added 0.1%	115,768 $733,000
Q1 2021 May 14, 2021	BUY	$6.6 - $9.0 $304,999 - $415,908	46,212 Added 66.55%	115,647 $894,000
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $513,819 - $1.02 Million	69,435 New	69,435 $578,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.